Understanding how changes in gene regulation affect lung disease
Maladaptive epigenetic control of MUC5B transcription in pulmonary fibrosis
This study is looking at how changes in our genes might affect a specific gene linked to idiopathic pulmonary fibrosis (IPF), a serious lung disease, by comparing lung cells from healthy people and those with IPF to better understand what causes the disease and its symptoms.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Colorado Denver NIH-funded |
| Lab location | 1 site (Aurora, UNITED STATES) |
| Project ID | NIH-10815869 on NIH RePORTER |
What this research studies
This research investigates the mechanisms behind increased expression of the MUC5B gene, which is linked to idiopathic pulmonary fibrosis (IPF), a severe lung disease. The team will analyze how epigenetic changes influence MUC5B expression in lung cells from both healthy individuals and those with IPF. By exploring these molecular processes, the research aims to uncover the factors that contribute to the development of IPF and its associated symptoms. The study will involve advanced techniques like ATAC sequencing to assess chromatin accessibility and gene regulation.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with idiopathic pulmonary fibrosis or those at high risk due to genetic factors.
Not a fit: Patients with other forms of lung disease or those without a genetic predisposition to IPF may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new therapeutic strategies for treating or preventing idiopathic pulmonary fibrosis.
How similar studies have performed: Previous research has shown promising results in understanding gene regulation in lung diseases, suggesting that this approach could yield valuable insights.
Where this research is happening
Aurora, UNITED STATES
- University of Colorado Denver — Aurora, United States (Active)
Researchers
- Principal investigator: Gerber, Anthony N — University of Colorado Denver
- Study coordinator: Gerber, Anthony N
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.